Services Will Accelerate Access to Public
Health Data to Improve Health Outcomes
RESTON,
Va., Nov. 1, 2023 /PRNewswire/ -- The National
Institutes of Health (NIH) National Library of Medicine (NLM)
recently awarded global consulting and technology services provider
ICF (NASDAQ:ICFI) two agreements with a combined value of
$31 million to provide biomedical and
technical expertise, as well as data management and digital
modernization services.
The first agreement is a new multiple-award blanket purchase
agreement (BPA) to collect, curate, and enhance access to critical
biomedical and public health data. ICF's efforts will improve data
delivery to health researchers, professionals and the public so
vital health decisions can quickly be made. The BPA has a term of
three years, including a one-year base and two one-year options.
ICF has also been awarded five new task orders under the BPA with a
combined value of $4 million to
provide health expertise, systems maintenance and long-range
planning support.
The second agreement is an 18-month, $27
million recompete contract for the operation, maintenance
and modernization of ClinicalTrials.gov, a project ICF has
supported since 2009. The company will leverage its clinical
research expertise and cutting-edge technology solutions to deliver
scientifically accurate information to help patients, caregivers,
healthcare professionals and researchers make more informed health
decisions.
"As a longstanding partner to NIH and NLM, ICF has consistently
provided complex technical and scientific expertise, advanced data
analytics and enterprise-wide digital modernization and cloud
services to support a wide range of critical agency programs," said
Jennifer Welham, ICF senior vice
president for health, people and human services. "We are eager to
continue providing these skills and innovative solutions to further
NLM's mission of enabling researchers, clinicians and the public to
use the vast wealth of biomedical data for improved health."
For over 50 years, ICF has supported public health initiatives
for nearly all major federal agencies, including numerous agencies
and programs within the U.S. Department of Health and Human
Services. The company's over 2,000 health professionals, including
researchers, statisticians, epidemiologists, microbiologists,
toxicologists, geneticists and more, work hand in hand with its
over 2,000 technologists, data scientists and communicators to
deliver mission critical programs that improve public health
outcomes.
Read more about ICF's federal health and digital
transformation services.
About ICF
ICF is a global consulting and technology
services company with approximately 9,000 employees, but we are not
your typical consultants. At ICF, business analysts and policy
specialists work together with digital strategists, data scientists
and creatives. We combine unmatched industry expertise with
cutting-edge engagement capabilities to help organizations solve
their most complex challenges. Since 1969, public and private
sector clients have worked with ICF to navigate change and shape
the future. Learn more at icf.com.
Caution Concerning Forward-looking
Statements
Statements that are not historical facts
and involve known and unknown risks and uncertainties are
"forward-looking statements" as defined in the Private Securities
Litigation Reform Act of 1995. Such statements may concern our
current expectations about our future results, plans, operations
and prospects and involve certain risks, including those related to
the government contracting industry generally; our particular
business, including our dependence on contracts with U.S. federal
government agencies; our ability to acquire and successfully
integrate businesses; and the effects of the novel coronavirus
disease (COVID-19), or any other future pandemic, and related
national, state and local government actions and reactions, on the
health of our staff and that of our clients, the continuity of our
and our clients' operations, our results of operations and our
outlook. These and other factors that could cause our actual
results to differ from those indicated in forward-looking
statements that are included in the "Risk Factors" section of our
securities filings with the Securities and Exchange Commission. The
forward-looking statements included herein are only made as of the
date hereof, and we specifically disclaim any obligation to update
these statements in the future.
Contact: Lauren Dyke,
lauren.dyke@ICF.com, +1.571.373.5577
View original content to download
multimedia:https://www.prnewswire.com/news-releases/nih-selects-icf-for-31-million-in-biomedical-and-digital-modernization-work-301974737.html
SOURCE ICF
